Monoclonal antibody 2909 belongs to a class of potently neutralizing antibodies that recognize quaternary epitopes on HIV-1. Some members of this class, such as 2909, are strain specific, while others, such as antibody PG16, are broadly neutralizing; all, however, recognize a region on the gp120 envelope glycoprotein that includes two loops (V2 and V3) and forms appropriately only in the oligomeric HIV-1 spike (gp1203/gp413). Here we present the crystal structure of 2909 and report structure-function analysis with antibody chimeras composed of 2909 and other members of this antibody class. The 2909 structure was dominated by a heavy-chain third-complementarity-determining region (CDR H3) of 21 residues, which comprised 36 % of the combining...
SummaryAll previously characterized broadly neutralizing antibodies to the HIV-1 envelope glycoprote...
SummaryBroadly neutralizing monoclonal antibodies to HIV-1 are rare but invaluable for vaccine desig...
Antibodies m66.6 and 2F5 are the only effective humanHIV-1-neutralizing antibodies reported thus far...
SummaryThe quaternary neutralizing epitope (QNE) of HIV-1 gp120 is preferentially expressed on the t...
447-52D is a human monoclonal antibody isolated from a heterohybridoma derived from an HIV-1-infecte...
Antibody 10E8 is capable of effectively neutralizing HIV through its recognition of the membrane-pro...
The human monoclonal antibody (mAb) HK20 neutralizes a broad spectrum of primary HIV-1 isolates by t...
The human monoclonal antibody (mAb) HK20 neutralizes a broad spectrum of primary HIV-1 isolates by t...
HIV-1 is neutralized by a class of antibodies that preferentially recognize a site formed on the ass...
New broad and potent neutralizing HIV-1 antibodies have recently been described that are largely dep...
HIV-1 entry into host cells is mediated by the sequential binding of the envelope glycoprotein gp120...
Current human immunodeficiency virus-1 (HIV-1) vaccines elicit strain-specific neutralizing antibodi...
Antibodies that neutralize diverse strains of HIV-1 develop in ∼20% of HIV-1-infected individuals, a...
The outer domain of the HIV-1 gp120 envelope glycoprotein contains the epitope for broadly neutraliz...
Human immunodeficiency virus type 1 (HIV-1), the pathogen responsible for the onset of acquired immu...
SummaryAll previously characterized broadly neutralizing antibodies to the HIV-1 envelope glycoprote...
SummaryBroadly neutralizing monoclonal antibodies to HIV-1 are rare but invaluable for vaccine desig...
Antibodies m66.6 and 2F5 are the only effective humanHIV-1-neutralizing antibodies reported thus far...
SummaryThe quaternary neutralizing epitope (QNE) of HIV-1 gp120 is preferentially expressed on the t...
447-52D is a human monoclonal antibody isolated from a heterohybridoma derived from an HIV-1-infecte...
Antibody 10E8 is capable of effectively neutralizing HIV through its recognition of the membrane-pro...
The human monoclonal antibody (mAb) HK20 neutralizes a broad spectrum of primary HIV-1 isolates by t...
The human monoclonal antibody (mAb) HK20 neutralizes a broad spectrum of primary HIV-1 isolates by t...
HIV-1 is neutralized by a class of antibodies that preferentially recognize a site formed on the ass...
New broad and potent neutralizing HIV-1 antibodies have recently been described that are largely dep...
HIV-1 entry into host cells is mediated by the sequential binding of the envelope glycoprotein gp120...
Current human immunodeficiency virus-1 (HIV-1) vaccines elicit strain-specific neutralizing antibodi...
Antibodies that neutralize diverse strains of HIV-1 develop in ∼20% of HIV-1-infected individuals, a...
The outer domain of the HIV-1 gp120 envelope glycoprotein contains the epitope for broadly neutraliz...
Human immunodeficiency virus type 1 (HIV-1), the pathogen responsible for the onset of acquired immu...
SummaryAll previously characterized broadly neutralizing antibodies to the HIV-1 envelope glycoprote...
SummaryBroadly neutralizing monoclonal antibodies to HIV-1 are rare but invaluable for vaccine desig...
Antibodies m66.6 and 2F5 are the only effective humanHIV-1-neutralizing antibodies reported thus far...